Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Vecht

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
Neurology|May 1, 1997
99mTc-SPECT in the diagnosis of skull base metastasisB P Jansen, M Pillay, H G de Bruin, et al.
Journal of Neuroimmunology|April 1, 1997
Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's diseaseF Graus, J Dalmau, F Valldeoriola, et al.
Clinical Neurology and Neurosurgery|May 1, 1995
Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II studyP H Hilkens, M E van der Burg, J W Moll, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Leptomeningeal metastasis after surgical resection of brain metastasesT C van der Ree, D W Dippel, C J Avezaat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Paclitaxel (Taxol) induces cumulative mild neurotoxicityJ M van Gerven, J W Moll, M J van den Bent, et al.
Journal of Neuro-Oncology|April 3, 1998
The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumorC S Straathof, M J van den Bent, J Ma, et al.
Neurosurgery|August 1, 1997
Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignanciesA J Vincent, M C Esandi, C J Avezaat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationP H Hilkens, M E van der Burg, J W Moll, et al.
European Journal of Neurology|November 29, 2013
Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing scheduleP H Hilkens, A S Planting, M E van der Burg, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
Neurology|May 1, 1997
99mTc-SPECT in the diagnosis of skull base metastasisB P Jansen, M Pillay, H G de Bruin, et al.
Journal of Neuroimmunology|April 1, 1997
Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's diseaseF Graus, J Dalmau, F Valldeoriola, et al.
Clinical Neurology and Neurosurgery|May 1, 1995
Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II studyP H Hilkens, M E van der Burg, J W Moll, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Leptomeningeal metastasis after surgical resection of brain metastasesT C van der Ree, D W Dippel, C J Avezaat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Paclitaxel (Taxol) induces cumulative mild neurotoxicityJ M van Gerven, J W Moll, M J van den Bent, et al.
Journal of Neuro-Oncology|April 3, 1998
The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumorC S Straathof, M J van den Bent, J Ma, et al.
Neurosurgery|August 1, 1997
Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignanciesA J Vincent, M C Esandi, C J Avezaat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationP H Hilkens, M E van der Burg, J W Moll, et al.
European Journal of Neurology|November 29, 2013
Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing scheduleP H Hilkens, A S Planting, M E van der Burg, et al.
Pageof 8